NIH Public Access Author Manuscript Mol Genet Metab. Author manuscript; available in PMC 2012 August 1. NIH-PA Author Manuscript

First Page		Document Content
Alkaptonuria Type I tyrosinemia William A. Gahl Tyrosinemia Nitisinone Ochronosis Tyrosine National Institutes of Health Aortic valve replacement Medicine Health Chemistry		NIH Public Access Author Manuscript Mol Genet Metab. Author manuscript; available in PMC 2012 August 1. NIH-PA Author Manuscript Add to Reading List Source URL: www.ncbi.nlm.nih.gov Download Document from Source Website File Size: 696,03 KB Share Document on Facebook

	PBAC STAKEHOLDER MEETING OUTCOME STATEMENT NITISINONE FOR TYROSINAEMIA TYPE 1 4 February 2015 Department of Health, Canberra Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), clinicians with exp DocID: 11c5S - View Document
	PBAC STAKEHOLDER MEETING OUTCOME STATEMENT NITISINONE FOR TYROSINAEMIA TYPE 1 4 February 2015 Department of Health, Canberra Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), clinicians with DocID: 10LjO - View Document
	PBAC STAKEHOLDER MEETING OUTCOME STATEMENT NITISINONE FOR TYROSINAEMIA TYPE 1 4 February 2015 Department of Health, Canberra Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), clinicians with DocID: 1053v - View Document
	PBAC STAKEHOLDER MEETING OUTCOME STATEMENT NITISINONE FOR TYROSINAEMIA TYPE 1 4 February 2015 Department of Health, Canberra Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), clinicians with exp DocID: Zv8C - View Document
	Medical Information Sheet TYROSINEMIA What is tyrosinemia? Hereditary tyrosinemia is a genetic inborn error of metabolism associated with severe liver disease in infancy. The disease is inherited in an autosomal recessiv DocID: KhAK - View Document